NeuroAge Therapeutics: Funding, Investors & Team (Oct 2026)
NeuroAge Therapeutics is a biotech company focused on extending lifespan by creating new drugs that target biological brain aging and treat neurodegenerative diseases through the use of machine learning technology that tracks aging.
NeuroAge Therapeutics has raised $250k across 1 funding round on record, the most recent an undisclosed round of $250k announced in Mar 2024.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
NeuroAge Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2024.
NeuroAge Therapeutics Funding Rounds
NeuroAge Therapeutics Founders and Leadership Team
Contact details for the NeuroAge Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →NeuroAge Therapeutics Funding Compared to Other Health Care Startups
NeuroAge Therapeutics' latest round of $250k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NeuroAge Therapeutics in Health Care and San Francisco
Companies Similar to NeuroAge Therapeutics
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
NeuroAge Therapeutics Funding FAQs
What does NeuroAge Therapeutics do?
NeuroAge Therapeutics is a biotech company focused on extending lifespan by creating new drugs that target biological brain aging and treat neurodegenerative diseases through the use of machine learning technology that tracks aging.
How much funding has NeuroAge Therapeutics raised?
NeuroAge Therapeutics has raised $250k across 1 round on record. The most recent is an undisclosed round of $250k announced in Mar 2024.
When did NeuroAge Therapeutics last raise funding?
NeuroAge Therapeutics' most recent funding round on record is an undisclosed round of $250k, announced in Mar 2024.
Who founded NeuroAge Therapeutics?
FundedIQ lists Christin Glorioso (Founder) at NeuroAge Therapeutics.
Where is NeuroAge Therapeutics headquartered?
NeuroAge Therapeutics is based in San Francisco, California, United States.
How many employees does NeuroAge Therapeutics have?
NeuroAge Therapeutics is in the 1-10 employee band.
How does NeuroAge Therapeutics' funding compare to other Health Care startups?
NeuroAge Therapeutics' latest round of $250k is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's NeuroAge Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NeuroAge Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.